CTOs on the Move


 
Ivenix, Inc. is a venture-backed medical device company with a vision to transform infusion delivery in every care setting, globally. The company is focused on bringing its first product to market, a new and innovative infusion management system for hospitals. The system combines integrated state-of-the-art information technology and simplicity with an adaptive fluid delivery platform that continuously measures flow. The company is headquartered in Amesbury, Massachusetts.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.ivenix.com
  • 21 Water St
    Amesbury, MA USA 01913
  • Phone: 978.792.5000

Executives

Name Title Contact Details

Funding

Ivenix raised $42M on 09/01/2015

Similar Companies

Med MatRx

Med MatRx is a Monaca, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Long Beach Prescription Pharmacy

Long Beach Prescription Pharmacy is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newport Beach, CA. To find more information about Long Beach Prescription Pharmacy, please visit www.ipmrx.com

Opus Healthcare Solutions

Opus Healthcare Solutions is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vyne Medical

Vyne Medical serves a growing base of more than 800 active hospital and healthcare system clients nationwide. Best practices are hardwired through technology solutions proven to help hospitals achieve sustainable top performance. Our solutions create a unified view of patient health data, capturing information at the point of exchange and making it available at the point of need for faster response times, smoother transitions, improved patient experience, and better health outcomes.

Aegea Medical

AEGEA Medical was founded in 2008 to develop technology that aspires to utilize water vapor to treat a variety of women`s health conditions. Led by an experienced management team, and supported by a committed investor group, AEGEA Medical has established an expanding Intellectual Property (IP) portfolio.